Grant: Pr. Gr.- PA: Sex/Gender in Health Res.- Understanding sex/gender mech./processes
University of Guelph
$100,000.00
The impact of menopause on acute myocardial infarctions and the use of estrogen receptor agonists to protect the heart
EF 2025-26
Résumé
Females have lower rates of cardiovascular disease (CVD) death than males early in life. After menopause this reverses and women have higher mortality rates. In fact, women who have heart attacks are more likely to die than men. Higher rates of heart attack mortality for females are partly due to inequities in healthcare access and delivery, but differences remain when these disparities are removed.
A barrier to understanding how menopause impacts women's CVD risk has been the lack of an animal model that mimics the changes of menopause. Removal of ovaries from lab animals replicates the decrease in estrogens, but its sudden onset mimics how <20% of women enter menopause. Most women undergo a gradual transition called 'perimenopause' which lasts up to a decade. We have a model of menopause in which mice injected with 4-vinylcyclohexene diepoxide experience perimenopause before developing the ovarian failure of menopause. We will use this model to investigate how the heart changes across the phases of menopause. We will expose hearts to coronary artery ligation to mimic a heart attack and measure molecules that protect the heart against the stress of a heart attack to understand when and how the increased risk of mortality rises in peri- and postmenopausal women.
Estrogens protect against CVD in premenopausal women and their loss contributes to increased CVD mortality after menopause. Chronic estrogen supplementation has unclear benefits for cardiovascular health, but our preliminary data show a novel treatment in which hearts are acutely exposed to estrogen mimetics after a heart attack limits injury. Whether this clinically viable treatment is effective after menopause has not been tested, nor has the effectiveness of perimenopausal estrogens. We will determine if acute exposure to estrogenic compounds protects against heart attack injury in the postmenopausal environment and chronic estrogen in perimenopause, and identify the mechanisms that mediate protection.
Programme
Pr. Gr.- PA: Sex/Gender in Health Res.- Understanding sex/gender mech./processes
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
555044
Name
Pyle Glen W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Gender, Sex & Health
Projecttitle
The impact of menopause on acute myocardial infarctions and the use of estrogen receptor agonists to protect the heart
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Pr. Gr.- PA: Sex/Gender in Health Res.- Understanding sex/gender mech./processes
Keyworddelim
Acute Myocardial Infarction; Estrogen Receptors; Menopause
Abstract
Females have lower rates of cardiovascular disease (CVD) death than males early in life. After menopause this reverses and women have higher mortality rates. In fact, women who have heart attacks are more likely to die than men. Higher rates of heart attack mortality for females are partly due to inequities in healthcare access and delivery, but differences remain when these disparities are removed.
A barrier to understanding how menopause impacts women's CVD risk has been the lack of an animal model that mimics the changes of menopause. Removal of ovaries from lab animals replicates the decrease in estrogens, but its sudden onset mimics how <20% of women enter menopause. Most women undergo a gradual transition called 'perimenopause' which lasts up to a decade. We have a model of menopause in which mice injected with 4-vinylcyclohexene diepoxide experience perimenopause before developing the ovarian failure of menopause. We will use this model to investigate how the heart changes across the phases of menopause. We will expose hearts to coronary artery ligation to mimic a heart attack and measure molecules that protect the heart against the stress of a heart attack to understand when and how the increased risk of mortality rises in peri- and postmenopausal women.
Estrogens protect against CVD in premenopausal women and their loss contributes to increased CVD mortality after menopause. Chronic estrogen supplementation has unclear benefits for cardiovascular health, but our preliminary data show a novel treatment in which hearts are acutely exposed to estrogen mimetics after a heart attack limits injury. Whether this clinically viable treatment is effective after menopause has not been tested, nor has the effectiveness of perimenopausal estrogens. We will determine if acute exposure to estrogenic compounds protects against heart attack injury in the postmenopausal environment and chronic estrogen in perimenopause, and identify the mechanisms that mediate protection.
Competitiondate
202509
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pyle, Glen W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~